Kevin M Klucher

This inventor holds 45 USPTO granted patents and 17 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Cytokine Proteins. Top assignee: Zymogenetics, Inc.. Active years: 2006-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin M Klucher. Retrieved from https://idiyas.com/inventor/kevin-m-klucher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 45 (Patent Applications = 17)

% Patents Active = 86.7

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 5.8

ph-index = 18

Forward Citations = 708(Granted Patents)

Company Filing History:

45 out of 723

Zymogenetics, Inc.

patents

Years Active: 2006-2016

Loading Chart...

Areas of Expertise:

IL-28

IL-29

Cytokine

Cancer Treatment

Viral Infection

Hepatitis

Antibodies

Polynucleotide

Cysteine Mutants

Autoimmune Disorders

Dengue Virus

Homogeneous Preparations

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9499598 - Mutants of IL-29 (2016-11-22),

2. 8816053 - Methods for treating viral infection using IL-28 and IL-29 cysteine mutants (2014-08-26),

3. 8734776 - Mutants of IL-29 (2014-05-27),

4. 8361954 - Use of IL-28 and IL-29 to treat cancer and autoimmune disorders (2013-01-29),

5. 8343476 - Method of using IL-29 cystehne mutant to treat hepatitis C and hepatitis B (2013-01-01),

6. 8318147 - Use of IL-29 for treating a dengue virus infection (2012-11-27),

7. 8283448 - Methods for treating viral infection using IL-28 and IL-29 cysteine mutants (2012-10-09),

8. 8231866 - Cytokine protein family (2012-07-31),

9. 8124065 - Cytokine Protein Family (2012-02-28),

10. 7910313 - Cytokine protein family (2011-03-22),

11. 7829076 - Method of using interferon-like potein ZCYTO20 (IL-28A) or ZCYTO22(IL-28B) to treat hepatitis B (2010-11-09),

12. 7786075 - Use of IL-28 and IL-29 to treat cancer and autoimmune disorders (2010-08-31),

13. 7727518 - Method of using IL-29 cysteine mutant to treat hepatitis C and hepatitis B (2010-06-01),

14. 7662927 - Antibodies to ZCYTO20 (IL-28A) and ZCYTO22 (IL-28B) (2010-02-16),

15. 7662590 - Polynucleotide encoding an IL-28A polypeptide (2010-02-16),

Title: The Innovative Mind of Kevin M Klucher

Introduction: Kevin M Klucher, a talented inventor based in Bellevue, WA, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Kevin M Klucher holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing new solutions to complex problems.

Career Highlights: Throughout his career, Kevin M Klucher has demonstrated a keen ability to identify gaps in the market and develop innovative products to fill those voids. His dedication to pushing the boundaries of technology has led to the creation of several successful inventions.

Collaborations: Kevin M Klucher has collaborated with leading tech companies and research institutions to further his inventions and bring them to market. His ability to work effectively in a team setting has been instrumental in the success of many of his projects.

Conclusion: Kevin M Klucher's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions to technology continue to inspire and shape the future of innovation.

Profile summary based on public USPTO records.